معرفی
Dr. Quyen Nguyen is a Professor in the Department of Surgery at UC San Diego School of Medicine and Associate Director of Training and Education at the Moores Cancer Center. She holds a combined MD/PhD from Washington University School of Medicine, where her PhD research focused on synaptic maintenance and nerve regeneration using in-vivo imaging in transgenic mice. Her clinical expertise includes facial nerve disorders, skull base surgery, and cochlear implants. Dr. Nguyen pioneered 'color-coded surgery' using fluorescence-guided techniques, collaborating with Nobel laureate Dr. Roger Tsien. She leads NIH-funded research (R01 grants) and founded Alume Biosciences to commercialize nerve-localization agents. Her work is highlighted in high-impact journals and media, including a TED Talk viewed over a million times. Key honors include the 2014 PECASE award from the U.S. government.
Education: MD/PhD (Washington University School of Medicine). Clinical training: General Surgery Internship at Barnes Jewish Hospital, residency and fellowship at UCSD. Board certifications: Head and Neck Surgery, Neurotology/Skull Base Surgery.
Research interests span nerve regeneration, fluorescence imaging in surgery, and molecular navigation systems. Over 150 publications include work on facial nerve visualization, cancer imaging, and surgical innovation. Her lab develops tools like ratiometric activatable cell-penetrating peptides (ACPPs) for real-time tumor detection. Collaborations span biomedical engineering, oncology, and nanotechnology.
Grants: NIH R01CA158448 (2011-2018), R56EB025910 (2018-2020). Awards: PECASE (2014), Burroughs-Wellcome Fund grants. Leadership: Director of UCSD's Facial Nerve Clinic since 2009, leading multidisciplinary care for facial dysfunctions. Active in translational research and industry partnerships through Alume Biosciences.
Labs/Teams: Molecular Imaging Lab focusing on surgical navigation systems. Key projects: Live Molecular Navigation (LMN) for cancer surgery, facial nerve preservation techniques. Future work emphasizes clinical translation of fluorescence-guided technologies.
